MENU
+Compare
OKUR
Stock ticker: NASDAQ
AS OF
Jul 10, 04:59 PM (EDT)
Price
$2.55
Change
+$0.01 (+0.39%)
Capitalization
34.45M

OKUR OnKure Therapeutics Inc Forecast, Technical & Fundamental Analysis

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies... Show more

OKUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for OKUR with price predictions
Jul 09, 2025

OKUR in upward trend: price rose above 50-day moving average on July 08, 2025

OKUR moved above its 50-day moving average on July 08, 2025 date and that indicates a change from a downward trend to an upward trend. In of 1 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 10 cases where OKUR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OKUR just turned positive on July 09, 2025. Looking at past instances where OKUR's MACD turned positive, the stock continued to rise in of 3 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OKUR advanced for three days, in of 18 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OKUR moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 similar instances where the indicator moved out of overbought territory. In of the 1 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OKUR as a result. In of 9 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OKUR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.380) is normal, around the industry mean (17.327). P/E Ratio (62.481) is within average values for comparable stocks, (59.374). OKUR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.418). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (272.335).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OKUR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OKUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
OKUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

OKUR is expected to report earnings to fall 94.12% to -7 cents per share on November 06

OnKure Therapeutics Inc OKUR Stock Earnings Reports
Q3'24
Est.
$-0.07
Q1'25
Missed
by $0.63
Q4'24
Missed
by $1.30
The last earnings report on May 06 showed earnings per share of -119 cents, missing the estimate of -56 cents. With 23.79K shares outstanding, the current market capitalization sits at 34.45M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRSP60.085.26
+9.60%
CRISPR Therapeutics AG
SOND2.770.07
+2.59%
Sonder Holdings
SAN8.880.19
+2.19%
Banco Santander SA
ALEX17.850.05
+0.28%
Alexander & Baldwin
PLL6.47-0.06
-0.92%
Piedmont Lithium